PRESS RELEASE published on 10/06/2026 at 18:30, 1 month 3 days ago Avolta’s Hudson secures new 20-year duty-free contract at Seattle-Tacoma International Avolta's Hudson brand secures new 20-year duty-free contract at Seattle-Tacoma International Airport, expanding retail space and offering unique experiences for travelers Avolta Travel Retail Duty-Free Contract Hudson Seattle-Tacoma International
PRESS RELEASE published on 10/06/2026 at 18:16, 1 month 3 days ago BOXABL (NASDAQ: BXBL) Adds Former EY Audit Partner Timothy Goldsmith to Board as Audit Committee Chair Austin, Texas, October 6th, 2026, FinanceWire
PRESS RELEASE published on 10/06/2026 at 18:16, 1 month 3 days ago BOXABL (NASDAQ: BXBL) Adds Former EY Audit Partner Timothy Goldsmith to Board as Audit Committee Chair Austin, Texas, United States, October 6th, 2026, FinanceWire
PRESS RELEASE published on 10/06/2026 at 18:16, 1 month 3 days ago Greenland Mines (NASDAQ: GRML) Exercises Option to Increase AnorTech Stake to 19.9% Austin, Texas, October 6th, 2026, FinanceWire
PRESS RELEASE published on 10/06/2026 at 18:16, 1 month 3 days ago Greenland Mines (NASDAQ: GRML) Exercises Option to Increase AnorTech Stake to 19.9% Austin, Texas, United States, October 6th, 2026, FinanceWire
REGULATED PRESS RELEASE published on 10/06/2026 at 18:15, 1 month 3 days ago AXA: Information relating to the number of voting rights and shares making up the share capital on 30/09/2026 AXA, a French public company, discloses information on total shares and voting rights according to French Commercial Code and AMF regulations Voting Rights French Commercial Code AXA AMF Regulations French Public Company
PRESS RELEASE published on 10/06/2026 at 18:00, 1 month 3 days ago Silynxcom (NYSE American: SYNX) Receives Two Purchase Orders Totalling Approximately $400,000 From a Leader in Global Defense Austin, Texas, October 6th, 2026, FinanceWire
PRESS RELEASE published on 10/06/2026 at 18:00, 1 month 3 days ago Quantum BioPharma (NASDAQ: QNTM) Enters Study Start-Up Agreement for Lucid-MS Phase 2 Trial Austin, Texas, United States, October 6th, 2026, FinanceWire
PRESS RELEASE published on 10/06/2026 at 18:00, 1 month 3 days ago Quantum BioPharma (NASDAQ: QNTM) Enters Study Start-Up Agreement for Lucid-MS Phase 2 Trial Austin, Texas, October 6th, 2026, FinanceWire
PRESS RELEASE published on 10/06/2026 at 18:00, 1 month 3 days ago ARVERNE GROUP: Total number of shares and voting rights in the share capital as of September 30, 2026 Arverne Group discloses total number of shares and voting rights in the share capital as of September 30, 2026, in compliance with French Commercial Code Voting Rights French Commercial Code Shares Arverne Group Geothermal Solutions
Published on 11/09/2026 at 23:00, 2 hours 19 minutes ago LNG Energy Group Announces Issuance of Third Partial Revocation Order and Proposed Shares-for-Debt Settlement
Published on 11/09/2026 at 22:32, 2 hours 47 minutes ago Announces Extension for Closing of Private Placement of Convertible Promissory Notes
Published on 11/09/2026 at 22:15, 3 hours 4 minutes ago Goldcliff Announces Closing of the Second and Final Tranche of its "LIFE" Offering and Completion of Drilling at Kettle Valley
Published on 11/09/2026 at 22:54, 2 hours 25 minutes ago EQS-Adhoc: Northern Data Group reports Q3 2026 and raises its FY 2026 revenue outlook communicated on 17 June 2026
Published on 11/09/2026 at 22:10, 3 hours 9 minutes ago Quantinuum to Participate in the Cantor Convergence 4th Annual Crypto, FinTech, AI & Energy Infrastructure Conference
Published on 11/09/2026 at 22:05, 3 hours 14 minutes ago Mayr-Melnhof Karton AG: MM Group to sell majority stake in its Packaging business to KPS Capital Partners and plans a special distribution to shareholders
Published on 11/09/2026 at 21:59, 3 hours 19 minutes ago EQS-Adhoc: MM Group to sell the majority stake in its Packaging business to KPS Capital Partners at an enterprise value of EUR 2.4 billion; special distribution to shareholders planned
Published on 11/09/2026 at 18:30, 6 hours 49 minutes ago Air Liquide has successfully issued a CHF 390 million multi-tranche bond
Published on 11/09/2026 at 17:35, 7 hours 44 minutes ago Disclosure of transactions in own shares from November 2 to November 6, 2026
Published on 11/09/2026 at 10:32, 14 hours 47 minutes ago Disclosure of shares outstanding and voting rights - 09.11.2026
Published on 11/09/2026 at 07:00, 18 hours 19 minutes ago bioMérieux receives U.S. FDA 510(k) clearance for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens including norovirus
![Logo of [UNKNOWN]](https://logos.symex.be/img/.jpg)
